A phase 3 comparative study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus everolimus in patients with advanced or metastatic renal cell carcinoma (mRCC) previously treated with anti-angiogenic therapy Meeting Abstract

  


Authors: Motzer, R. J.; Bono, P.; Tomita, Y.; Ravaud, A.; Waxman, I.; Gore, M. E.
Abstract Title: A phase 3 comparative study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus everolimus in patients with advanced or metastatic renal cell carcinoma (mRCC) previously treated with anti-angiogenic therapy
Meeting Title: 12th International Kidney Cancer Symposium
Journal Title: BJU International
Volume: 112
Issue: Suppl. 3
Meeting Dates: 2013 Oct 25-26
Meeting Location: Chicago, IL
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2013-11-01
Start Page: 10
Language: English
ACCESSION: WOS:000325992100016
PROVIDER: wos
Notes: Meeting Abstract: 15 -- 12th International Kidney Cancer Symposium -- OCT 25-26, 2013 -- Chicago, IL -- 3 -- SI -- Source: Wos